Forth Valley staff and patients contributed to vital research to find new treatments for some of the sickest people with Covid-19.
The RECOVERY trial tested a range of potential treatments for Covid-19 and discovered that Tocilizumab, an intravenous drug used to treat rheumatoid arthritis, along with Dexamethasone, can help reduce the need for intensive care and reduce length of stay.
